Novavax (NVAX)
(Delayed Data from NSDQ)
$13.85 USD
-1.11 (-7.42%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $13.86 +0.01 (0.07%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NVAX 13.85 -1.11(-7.42%)
Will NVAX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVAX
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Other News for NVAX
Novavax call volume above normal and directionally bullish
Novavax’s Promising Outlook: Strong Market Positioning and Strategic Partnerships Fuel Buy Rating
Novavax price target lowered by $7 at Jefferies, here's why
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today